At present, since COVID-19 has not yet been controlled, a series of prospective population studies with rigorous design and large sample should commence with protocol registration, and implementation in a timely manner, to produce reliable evidence for CM prevention of COVID-19 or similar emerging respiratory infectious diseases in the future.